Cytochrome P450-Mediated Metabolism and Nephrotoxicity ofN-(3,5-Dichlorophenyl)succinimide in Fischer 344 Rats

doi:10.1006/faat.1997.2321

Fundamental and Applied Toxicology

Volume 37, Issue 2, June 1997, Pages 117-124

Fundamental and Appl...

https://doi.org/10.1006/faat.1997.2321 Get rights and content

Abstract

The agricultural fungicideN-(3,5-dichlorophenyl)succinimide (NDPS) is nephrotoxic in rats. Previous studies have suggested that oxidative hepatic biotransformation is required for the induction of kidney damage. The experiments described in this paper were designed to further investigate the relationship between NDPS metabolism and nephrotoxicity using various modulators of cytochrome P450 activity. Male Fischer 344 rats were pretreated with the P450 inducers Aroclor 1254 (ARO), isoniazid (INH), 3-methylcholanthrene (3-MC), and phenobarbital (PB), or the P450 inhibitor 1-aminobenzotriazole (ABT). Control animals received vehicle only. NDPS metabolism was investigated using hepatocytes isolated from the various treatment groups. Separate experiments were also conducted to evaluate the effects of these pretreatments on NDPS-induced nephrotoxicity in rats. PB and ARO enhanced formation of the known nephrotoxic NDPS metabolites,N-(3,5-dichlorophenyl)-2-hydroxysuccinimide,N-(3,5-dichlorophenyl)-2-hydroxysuccinamic acid, andN-(3,5-dichlorophenyl)-3-hydroxysuccinamic acid, by the hepatocytes. In contrast, ABT inhibited formation of the nephrotoxic metabolites, whereas INH and 3-MC did not alter NDPS biotransformation. NDPS-induced renal damage was potentiated by pretreating the rats with PB or ARO and was attenuated by ABT. Compared with control animals, toxicity was unaffected by INH or 3-MC pretreatments. Thus, there was a correlation between pretreatments that induce P450-mediated NDPS metabolism and the effects that these compounds have on NDPS-induced nephrotoxicity. The data indicate that specific P450 isozymes metabolize NDPS to its hydroxylated products and suggest that these metabolites mediate the nephrotoxicity induced by NDPS.

References (35)

P.J. Harvison et al.
Nephrotoxic potential ofNN
Toxicol. Lett.
(1992)
C.M. Henesey et al.
Potential metabolism and cytotoxicity ofN
Toxicology
(1995)
G.L. Kellner-Weibel et al.
Nephrotoxic potential ofNN
Toxicol. Lett.
(1995)
G.A. Kyerematen et al.
Metabolism of nicotine by hepatocytes
Biochem. Pharmacol.
(1990)
P. Moldeus
Paracetamol metabolism and toxicity in isolated hepatocytes from rat and mouse
Biochem. Pharmacol.
(1978)
P. Moldeus et al.
Spectral studies on drug–cytochrome P450 interaction in isolated rat liver cells
Biochem. Biophys. Res. Commun.
(1973)
C.A. Mugford et al.
1-Aminobenzotriazole-induced destruction of hepatic and renal cytochromes in male Sprague–Dawley rats
Fundam. Appl. Toxicol.
(1992)
D.W. Nebert et al.
Substrate-inducible microsomal aryl hydroxylase in mammalian cell culture: I. Assay and properties of induced enzyme
J. Biol. Chem.
(1968)
T. Omura et al.
The carbon monoxide binding pigment of liver microsomes: I. Evidence for its hemoprotein nature
J. Biol. Chem.
(1964)
G.O. Rankin
Nephrotoxicity following acute administration ofN
Toxicology
(1982)

G.O. Rankin et al.

Onset and recovery of acuteN

Toxicology

(1984)

G.O. Rankin et al.

N

Toxicol. Lett.

(1985)

G.O. Rankin et al.

Deuterium isotope effect in acuteN

Life Sci.

(1986)

G.O. Rankin et al.

Effect of microsomal enzyme activity modulation onN

Toxicology

(1987)

G.O. Rankin et al.

Nephrotoxicity ofNin vivoin vitro

Toxicol. Appl. Pharmacol.

(1988)

G.O. Rankin et al.

Acute nephrotoxicity induced byN

Toxicol. Lett.

(1989)

D.E. Ryan et al.

Characterization of a major form of rat hepatic microsomal cytochrome P-450 induced by isoniazid

J. Biol. Chem.

(1985)

Cited by (16)

The palliative effect of camel milk on hepatic CYP1A1 gene expression and DNA damage induced by fenpropathrin oral intoxication in male rats
2021, Ecotoxicology and Environmental Safety
Citation Excerpt :
Anadón et al. (2013) reported that a type II pyrethroid, cylfuthrin, disturbs the CYP system in the liver through stimulation of CYP2E and CYP1A subfamilies. Several studies have linked the toxicity of several compounds to their P450- mediated metabolism (Gonzalez and Gelboin, 1994; Nyarko et al., 1997). Although the outcomes of PYRs genotoxicity tests have shown negative results, those of other assays have been variable and it has not been possible to draw definite conclusions about their genotoxicity (Surrallés et al., 1995).
The present study investigated the alleviating role of camel milk (CM) in the mitigation of fenpropathrin (FNP) type II pyrethroid induced oxidative stress, alterations of hepatic (CYP1A1) mRNA expression pattern, and DNA damage using the alkaline comet assay (SCGE) in male rats. Sixty male Sprague-Dawley rats were separated into six groups (n = 10): 1st control (C), 2nd corn oil (CO), 3rd (CM): gavaged CM 2ml/rat, 4th (FNP): gavaged FNP 7.09 mg/kg body weight (BW), 5th (FNP pro/co-treated): gavaged CM firstly for 15 days, then CM + FNP by the same mentioned doses and route, 6th (FNP + CM co-treated): gavaged FNP firstly followed by CM by the same mentioned doses and route. Rats were orally gavaged three times per week, day after day for 60 days. FNP exposure significantly reduced serum glutathione (GSH) levels, but significantly increased serum levels of superoxide dismutase (SOD), catalase (CAT), malondialdehyde (MDA), protein carbonyl (PCO), and 8hydroxy2deoxyguanosine (8OH2dG). Additionally, FNP exposure significantly up-regulated the mRNA expression levels of hepatic CYP1A1 and increased the SCGE indices in whole blood, liver, and spleen tissues of exposed male rats. Administration of CM significantly regulated the FNP induced oxidative stress, reduced hepatic CYP1A1 mRNA expression levels and values of comet assay indices particularly in the (CM + FNP pro/co-treated) group compared to the (FNP + CM co-treated) group. In conclusion, our results indicate, for the first time, that FNP retains an in vivo genotoxic potential at a dose of (1/10 LD₅₀) and up-regulated hepatic CYP1A1 mRNA expression in male rats. Additionally, CM supplements may improve the genotoxic outcomes, oxidative stress, and altered CYP1A1 mRNA expression induced by FNP particularly in the pro/concurrent-treatment compared to the concurrent treatment alone.
Pyrethroid insecticide lambda-cyhalothrin induces hepatic cytochrome P450 enzymes, oxidative stress and apoptosis in rats
2018, Science of the Total Environment
Citation Excerpt :
Although CYP enzymes normally generate metabolites with diminished biologic activity and represent a defense for detoxifying the ROS entities O2 and O22, there are numerous examples where these enzymes catalyze the metabolic activation of chemically inert agents to electrophiles (Ioannides and Parke, 1990; Guengerich et al., 1991; Hinson et al., 1994). The link between P450-mediated metabolism and toxicity of several compounds has been showed (Nyarko et al., 1997; Gonzalez and Gelboin, 1994). Because, to our knowledge, there is limited information on the ability of lambda-cyhalothrin to induce hepatic drug metabolizing enzymes (Yang et al., 2009; Abass et al., 2012), the present study was performed with the objective to establish if lambda-cyhalothrin interacts with microsomal CYP system in rat liver and to analyze whether oxidative stress, proinflammatory and apoptosis mechanisms should be also co-affected by this pyrethroid.
This study aimed to examine in rats the effects of the Type II pyrethroid lambda-cyhalothrin on hepatic microsomal cytochrome P450 (CYP) isoform activities, oxidative stress markers, gene expression of proinflammatory, oxidative stress and apoptosis mediators, and CYP isoform gene expression and metabolism phase I enzyme PCR array analysis. Lambda-cyhalothrin, at oral doses of 1, 2, 4 and 8 mg/kg bw for 6 days, increased, in a dose-dependent manner, hepatic activities of ethoxyresorufin O-deethylase (CYP1A1), methoxyresorufin O-demethylase (CYP1A2), pentoxyresorufin O-depentylase (CYP2B1/2), testosterone 7α- (CYP2A1), 16β- (CYP2B1), and 6β-hydroxylase (CYP3A1/2), and lauric acid 11- and 12-hydroxylase (CYP4A1/2). Similarly, lambda-cyhalothrin (4 and 8 mg/kg bw, for 6 days), in a dose-dependent manner, increased significantly hepatic CYP1A1, 1A2, 2A1, 2B1, 2B2, 2E1, 3A1, 3A2 and 4A1 mRNA levels and IL-1β, NFκB, Nrf2, p53, caspase-3 and Bax gene expressions. PCR array analysis showed from 84 genes examined (P < 0.05; fold change > 1.5), changes in mRNA levels in 18 genes: 13 up-regulated and 5 down-regulated. A greater fold change reversion than 3-fold was observed on the up-regulated ALDH1A1, CYP2B2, CYP2C80 and CYP2D4 genes. Ingenuity Pathway Analysis (IPA) groups the expressed genes into biological mechanisms that are mainly related to drug metabolism. In the top canonical pathways, Oxidative ethanol degradation III together with Fatty Acid α-oxidation may be significant pathways for lambda-cyhalothrin. Our results may provide further understanding of molecular aspects involved in lambda-cyhalothrin-induced liver injury.
Halogenated Hydrocarbons
2018, Comprehensive Toxicology: Third Edition
Halogenated hydrocarbons (HHCs) encompass a broad group of aliphatic and aromatic chemicals. Many are environmental contaminants or industrial solvents. This article focuses on select HHCs that are known to exhibit nephrotoxicity in animals and/or humans. Chemicals that are reviewed include select examples from haloalkanes, haloacids, haloalkenes, halogenated aromatics, halogenated ethers (which include some commonly used anesthetic agents), and ifosfamide and cyclophosphamide. The article is divided into processes involved in nephrotoxicity. The first major section summarizes metabolic pathways for bioactivation and/or detoxification. Metabolism comprises two major pathways: cytochrome P450 (CYP)-dependent oxidation, which can result in bioactivation or generate substrates for Phase II conjugation reactions; and glutathione-dependent bioactivation pathways, which involve subsequent metabolism by cysteine conjugate beta-lyase or flavin-containing monooxygenase. The next major section summarizes key features of acute and chronic nephrotoxicity, which typically involve single dose or short-term, high-dose exposures for acute and long-term, low-dose exposures for chronic. The final section summarizes select human health risk assessments for HHCs.
Induction of cytochrome P450-dependent mixed function oxidase activities and peroxisome proliferation by chloramine-T in male rat liver
2017, Food and Chemical Toxicology
Citation Excerpt :
Although the cytochrome P450 (CYP) enzymes normally generate metabolites with diminished biologic activity and represent a defense for detoxifying the ROS entities O2 and O22, there are numerous examples where these enzymes catalyze the metabolic activation of chemically inert agents to electrophiles (Ioannides and Parke, 1990; Guengerich et al., 1991; Hinson et al., 1994). The link between P450-mediated metabolism and toxicity of several compounds has been showed (Nyarko et al., 1997; Gonzalez and Gelboin, 1994). Because chloramine-T can potentially produce mutagenic electrophilic organoclorines and the ability of chloramine-T to induce hepatic drug metabolizing enzymes has not been reported, our study was performed with the objective to establish if chloramine-T interacts with microsomal CYP system in rat liver and to determine whether peroxisomal proliferation is also co-affected by chloramine-T.
Chloramine-T is an antimicrobial agent recognized for its disinfectant properties widely used in food industry. As an N-chloro-compound, chloramine-T contains electrophilic chlorine and in water it hydrolyses to hypochlorite. Chlorine as hypochlorous acid or hypochlorite is a very reactive chemical which can function as both an oxidant and halogenating agent. Because chloramine-T could be involved in the metabolic activation of drugs, in the present study the effects of chloramine-T on the activities of some drug metabolizing enzymes in rat liver microsomes and peroxisome proliferation were determined in vivo. Rats were treated orally with chloramine-T at doses of 1.25, 2.50, 5 and 10 mg/kg body weight (bw)/day for 6 days. The activities of CYP2E1, CYP1A1/2 CYP2B1/2, CYP3A4 and CYP4A1/2 enzymes significantly increased after treatment with 2.50, 5 and 10 mg/kg bw/day, in a dose-dependent manner as compared to control. This effect was not observed after chloramine-T treatment at dose of 1.25 mg/kg bw/day. Our results suggest that chloramine-T may potentiate the toxicity of many xenobiotics via metabolic activation and/or accumulation of reactive metabolites.
Nephrotoxic and hepatotoxic potential of imidazolidinedione-, oxazolidinedione- and thiazolidinedione-containing analogues of N-(3,5-dichlorophenyl)succinimide (NDPS) in Fischer 344 rats
2003, Toxicology
Nephrotoxicity of the agricultural fungicide N-(3,5-dichlorophenyl)succinimide (NDPS) in rats is believed to involve metabolism on the succinimide ring. To further investigate this hypothesis, we synthesized and tested the following NDPS analogues, which contain other cyclic imide rings and may therefore be metabolized differently than NDPS: 3-(3,5-dichlorophenyl)-2,4-oxazolidinedione (DCPO), 3-(3,5-dichlorophenyl)-2,4-imidazolidinedione (DCPI), 3-(3,5-dichlorophenyl)-1-methyl-2,4-imidazolidinedione (DCPM) and 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione (DCPT). Male Fischer 344 rats were administered DCPO, DCPI, DCPM, DCPT (0.6 or 1.0 mmol/kg, i.p. in corn oil), NDPS (0.6 mmol/kg, i.p. in corn oil) or corn oil (4 ml/kg). As evidenced by diuresis, proteinuria, elevated blood urea nitrogen levels, increased kidney weights and proximal tubular damage, NDPS produced severe nephrotoxicity in the rats. In contrast, DCPO, DCPI, DCPM and DCPT were mild nephrotoxicants. None of the compounds elevated serum alanine transferase activity or liver weights in the rats, however DCPT produced centrilobular necrosis. These experiments confirm that NDPS-induced nephrotoxicity is critically dependent on the presence of the succinimide ring. Furthermore, replacement of the succinimide ring with a thiazolidinedione ring produced a more pronounced effect on the liver than on the kidney. Liver damage has been reported in type II diabetic patients taking troglitazone, rosiglitazone and pioglitazone. Since these compounds also contain a thiazolidinedione ring, DCPT may be useful for investigating the role of this structural feature in hepatotoxicity.
Renal damage, metabolism and covalent binding following administration of the nephrotoxicant N-(3,5-dichlorophenyl)succinimide (NDPS) to male Fischer 344 rats
2002, Toxicology
Citation Excerpt :
Results of the toxicity studies (Table 1) suggested that dosages of 0.2 and 0.6 mmol/kg NDPS were non-nephrotoxic and nephrotoxic, respectively. Although vehicle control (i.e. corn oil treated) animals were not included in these studies, a dosage of 0.2 mmol/kg NDPS was previously shown to be essentially non-nephrotoxic at 6 h (Rankin et al., 1984), 24 h (Griffin and Harvison, 1998), and 48 h post-dosing (Nyarko et al., 1997). The rats were completely protected against NDPS-induced nephrotoxicity by ABT, which selectively destroys CYP activity (Mugford et al., 1992).
In vivo metabolism, nephrotoxicity and covalent binding to proteins were evaluated in male Fischer 344 rats that received [2,3-¹⁴C]-N-(3,5-dichlorophenyl)succinimide (¹⁴C-NDPS). Some animals were pretreated with the enzyme inducer phenobarbital (PB, 80 mg/kg per day, for 3 days, i.p. in saline) prior to receiving a non-nephrotoxic dose of ¹⁴C-NDPS (0.2 mmol/kg, i.p. in corn oil). Other rats were pretreated with the cytochrome P450 inhibitor 1-aminobenzotriazole (ABT, 100 mg/kg, 1 h prior to NDPS, i.p. in saline) before administration of a non-toxic or a toxic dose (0.2 or 0.6 mmol/kg, respectively, i.p. in corn oil) of ¹⁴C-NDPS. Non-pretreated animals received either dose of ¹⁴C-NDPS, but did not receive PB or ABT. All rats were sacrificed 6 h after administration of ¹⁴C-NDPS. Nephrotoxicity was monitored by measuring urine volume, urine protein concentrations, blood urea nitrogen levels, and kidney weights. The NDPS metabolic profile in tissue, blood, and urine was analyzed by HPLC. Covalent binding of ¹⁴C-NDPS-derived radioactivity to tissue proteins was also measured. Compared with non-pretreated rats, PB-pretreatment potentiated the toxicity of the non-toxic dose of ¹⁴C-NDPS. In contrast, ABT-pretreatment protected the rats against NDPS nephrotoxicity. The amount of N-(3,5-dichlorophenyl)-2-hydroxysuccinamic acid (2-NDHSA), an oxidative, nephrotoxic metabolite of NDPS, was elevated in kidney homogenates and urine by PB-pretreatment (0.2 mmol/mg NDPS). ABT pretreatment inhibited NDPS metabolism at both doses. Covalent binding of ¹⁴C-NDPS (0.2 mmol/kg)-derived radioactivity to renal and plasma proteins was higher in the PB-pretreated rats than in the non-pretreated animals. In contrast, ABT-pretreatment partially inhibited covalent binding at both doses of ¹⁴C-NDPS. Our results suggest that there is a relationship between oxidative metabolism of NDPS, covalent binding of an NDPS metabolite to renal proteins, and NDPS-induced nephrotoxicity in rats.

View all citing articles on Scopus

^☆: K. SnellB. Mullock, Eds.

¹: To whom correspondence should be addressed. Fax: 215-895-1161. E-mail: [email protected].

View full text

Regular ArticleCytochrome P450-Mediated Metabolism and Nephrotoxicity ofN-(3,5-Dichlorophenyl)succinimide in Fischer 344 Rats☆

Abstract

Toxicol. Lett.

Toxicology

Toxicol. Lett.

Biochem. Pharmacol.

Biochem. Pharmacol.

Biochem. Biophys. Res. Commun.

Fundam. Appl. Toxicol.

J. Biol. Chem.

J. Biol. Chem.

Toxicology

Toxicology

Toxicol. Lett.

Life Sci.

Toxicology

Toxicol. Appl. Pharmacol.

Toxicol. Lett.

J. Biol. Chem.

Regular Article
Cytochrome P450-Mediated Metabolism and Nephrotoxicity ofN-(3,5-Dichlorophenyl)succinimide in Fischer 344 Rats☆